Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Cloning and Expression
Library Construction
cDNA Synthesis
RNA
RNA
DcR2 shRNA Plasmid (h)
Supplier Images
DcR2 shRNA Plasmid (h)
DcR2 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(5)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
DcR2 shRNA Plasmid (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
DcR2 shRNA Plasmid (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$592.00
Supplier Page
View Company Product Page
Catalog Number
sc-35185-SH
Quantity
20 µg
RNA Type
shRNA Clones
Vector Type (Standardized)
Lentiviral
Type
shRNA Plasmid
Species
human
NCBI Full Gene Name
TNF receptor superfamily member 10d
NCBI Gene Aliases
CD264, DCR2, TRAIL-R4, TRAILR4, TRUNDD
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (5)
(1)
Ischemic Preconditioning Upregulates Decoy Receptors to Protect SH-SY5Y Cells from OGD Induced Cellular Damage by Inhibiting TRAIL Pathway and Agitating PI3K/Akt Pathway
Molecular neurobiology
September 1, 2020
Jin W, Xu W, Zhang X, Ren CC.
(2)
DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells
Cancer gene therapy
December 1, 2007
Sanlioglu AD, Karacay B, Koksal IT, Griffith TS, Sanlioglu S.
(3)
Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis
Rheumatology (Oxford, England)
May 1, 2007
Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, Sanlioglu S.
(4)
Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells
Human gene therapy
January 1, 2007
Aydin C, Sanlioglu AD, Karacay B, Ozbilim G, Dertsiz L, Ozbudak O, Akdis CA, Sanlioglu S.
(5)
Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells
BMC cancer
May 25, 2005
Sanlioglu AD, Dirice E, Aydin C, Erin N, Koksoy S, Sanlioglu S.
<<
<
>
>>
Reviews
Be the First to Write a Review!
DcR2 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$592.00
Product Specs
Company Info
Citations
Reviews
Back To Top